Pre-order Enquiry
Request Free Sample
Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-14901953 | Publishing Date : 19-Nov-2019 | No. of pages : 104
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Table of Contents1 Age-Related Macular Degeneration (AMD) Therapeutics Market Overview
1.1 Product Overview and Scope of Age-Related Macular Degeneration (AMD) Therapeutics
1.2 Classification of Age-Related Macular Degeneration (AMD) Therapeutics by Types
1.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Types in 2018
1.2.3 Wet AMD
1.2.4 Dry AMD
1.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market by Application
1.3.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Market by Regions
1.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Age-Related Macular Degeneration (AMD) Therapeutics (2014-2024)
2 Company Profiles
2.1 Amgen Inc.
2.1.1 Business Overview
2.1.2 Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bausch Health Companies, Inc.
2.3.1 Business Overview
2.3.2 Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 F. Hoffmann-La Roche Ltd.
2.4.1 Business Overview
2.4.2 Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Regeneron Pharmaceuticals Inc.
2.5.1 Business Overview
2.5.2 Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Competition, by Players
3.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Age-Related Macular Degeneration (AMD) Therapeutics Players Market Share
3.2.2 Top 10 Age-Related Macular Degeneration (AMD) Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions
4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Market Share by Regions
4.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries
5.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries (2014-2019)
5.2 USA Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries
6.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries
7.1 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries (2014-2019)
7.2 China Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries
8.1 South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Age-Related Macular Degeneration (AMD) Therapeutics by Countries
9.1 Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment by Type
10.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Type (2019-2024)
10.3 Wet AMD Revenue Growth Rate (2014-2024)
10.4 Dry AMD Revenue Growth Rate (2014-2024)
11 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment by Application
11.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Research Institute Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast (2019-2024)
12.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast (2019-2024)
12.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Figures, Tables and Charts Available in Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
List of Tables and FiguresFigure Age-Related Macular Degeneration (AMD) Therapeutics Picture
Table Product Specifications of Age-Related Macular Degeneration (AMD) Therapeutics
Table Global Age-Related Macular Degeneration (AMD) Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Types in 2018
Figure Wet AMD Picture
Figure Dry AMD Picture
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Research Institute Picture
Figure Other Picture
Table Global Market Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
Table Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
Table Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Companies, Inc. Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
Table Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
Table F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Regeneron Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Type and Applications
Table Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Players (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Players in 2017
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share in 2018
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Regions in 2018
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries (2014-2019)
Table North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries in 2018
Figure USA Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries in 2018
Figure China Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Countries (2014-2019)
Table South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Type (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Type (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Type in 2018
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global Wet AMD Revenue Growth Rate (2014-2019)
Figure Global Dry AMD Revenue Growth Rate (2014-2019)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Application (2014-2019)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Application (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Application (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Application in 2018
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Research Institute Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Forecast (2019-2024)
Keyplayers in Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Amgen Inc.Novartis AG
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Regeneron Pharmaceuticals Inc.
